Human Reproduction, Vol. 18, No. 5, 907-912,
May 2003
© 2003 European Society of Human Reproduction and Embryology
Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility
Current best evidence for the advanced treatment of unexplained subfertility
Department of Obstetrics and Gynecology, McMaster University, Hamilton and Department of Obstetrics and Gynaecology, Dalhousie University, Halifax, Canada
1 To whom correspondence should be addressed at: 400 Maders Cove Road, RR No.1 Mahone Bay, Nova Scotia, Canada, B0J 2E0. E-mail: collinsj{at}auracom.com
When conventional treatment of unexplained infertility has not been successful, the next choice lies between either gonadotrophin treatment with intrauterine insemination (FSH/IUI) and IVF. Cohort studies indicate that FSH/IUI is less effective while the cost per birth is higher with IVF. The relevant evidence should come from randomized controlled trials, but the results need to be recalculated for the outcome of greatest interest, a singleton live birth. Judged by this standard, FSH/IUI is statistically superior to no treatment, but the effect is small in couples with unexplained infertility. By the same standard, IVF is superior to FSH/IUI treatment, but this benefit is achieved only at considerable cost. The evidence is not robust, comprising only a few trials which involve a minute fraction of the existing patients with unexplained infertility. Current best evidence is consistent with a progression from low-tech to high-tech treatment, but it is not convincing enough to support a rigid management protocol. A large multicentre factorial trial is needed to evaluate the relative value of existing empiric treatments for unexplained infertility.
Key words: cost-effectiveness/gonadotrophins/intrauterine insemination/IVF
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S Bhattacharya, K Harrild, J Mollison, S Wordsworth, C Tay, A Harrold, D McQueen, H Lyall, L Johnston, J Burrage, et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial BMJ, August 7, 2008; 337(aug07_2): a716 - a716. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A El-Toukhy and Y. Khalaf Treatment of unexplained infertility BMJ, August 7, 2008; 337(aug07_2): a772 - a772. [Full Text] |
||||
![]() |
P.G. Crosignani, E. Somigliana, and on behalf of the Intrauterine Insemination (IUI) S Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial Hum. Reprod., February 1, 2007; 22(2): 500 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Brosens, S. Gordts, M. Valkenburg, P. Puttemans, R. Campo, and S. Gordts Investigation of the infertile couple: when is the appropriate time to explore female infertility? Hum. Reprod., August 1, 2004; 19(8): 1689 - 1692. [Abstract] [Full Text] [PDF] |
||||

